Literature DB >> 30150106

Vascular permeability and hemodynamic effects of ulinastatin on organs affected by shock during early burn injury.

Shiyan Li1, Weixi Yang2, Liangliang Zhou1, Dekang Nie3, Haizhou Yu4.   

Abstract

BACKGROUND: This study aimed to investigate the preventive and therapeutic effects of ulinastatin on the recovery of vascular permeability and hemodynamics in shock-affected organs during early burn injury.
METHODS: Twelve beagle dogs with 35% TBSA full-thickness burn were randomized to control group (CG, n = 6) and ulinastatin group (UG, n = 6).Hemodynamic parameters were determined by PICCO before burn and at 0.5 h, 1 h, 2 h, 4 h, 6 h, 8 h post-burn. Plasma volume (PV) were deduced through indocyanine green (ICG) method. Blood samples were drawn to determine hematocrit (HCT) at each time. Intestinal mucosal blood flow (IMBF) was determined by laser Doppler flowmetry. Evans blue (EB) method was taken to measure the vasopermeability of heart, liver, spleen, kidney and small intestine. Pathological tests were also performed.
RESULTS: Compared with CG,UG had better hemodynamic parameters (improved mean arterial pressure and cardiac output) (P < 0.05). HCT rose in both groups, while in UG the rising extent was less than that in CG (P < 0.05). PV and IMBF in both groups declined, but in UG the extent were less (P < 0.05). Both EB content of liver, spleen, kidney and small intestine in UG were much lower than that in CG at 8 h post-burn (P < 0.05). Pathological changes showed that severe injury was significantly ameliorated in UG.
CONCLUSIONS: Ulinastatin helped to moderate the quick loss of circulatory volume and improved hemodynamic indices in beagle dogs who had suffered 35% third degree burn injuries. It may serve as a therapeutic agent for reducing vascular permeability, thereby preventing fluid loss following major burn injury.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Burn; Hypovolemic shock; Organ function; Ulinastatin; Vasopermeability

Mesh:

Substances:

Year:  2018        PMID: 30150106     DOI: 10.1016/j.ajem.2018.05.038

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   4.093


  4 in total

1.  Ulinastatin alleviates cerebral ischemia-reperfusion injury in rats by activating the Nrf-2/HO-1 signaling pathway.

Authors:  Lei Cui; Wei Cao; Yanmin Xia; Xiaofang Li
Journal:  Ann Transl Med       Date:  2020-09

2.  Change of Hemoglobin Levels in the Early Post-cardiac Arrest Phase Is Associated With Outcome.

Authors:  Christoph Schriefl; Christian Schoergenhofer; Florian Ettl; Michael Poppe; Christian Clodi; Matthias Mueller; Juergen Grafeneder; Bernd Jilma; Ingrid Anna Maria Magnet; Nina Buchtele; Magdalena Sophie Boegl; Michael Holzer; Fritz Sterz; Michael Schwameis
Journal:  Front Med (Lausanne)       Date:  2021-06-09

3.  The combination of ulinastatin and 5-fluorouracil synergistically inhibits hepatocellular carcinoma growth.

Authors:  Xueli Hu; Jie Ding; Ge Wang; Xianming Zhang
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

4.  Effect of Ulinastatin Combined with Xingnaojing Injection on Severe Traumatic Craniocerebral Injury and Its Influence on Oxidative Stress Response and Inflammatory Response.

Authors:  Zexin An; Yong Yin; Lei Zhang; Bo Wang; Tao Cui; Meng Li; Jianwei Zhuo; Jing Zhang; Kai Wang; Wenwen Zhang; Meng Ji; Jilin Sun; Yinong Xu
Journal:  Biomed Res Int       Date:  2022-01-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.